Profilo
John Valliant is the founder of the Centre For Probe Development & Commercialization, holding the title of Independent Director & Principal Investigator since 2008.
Dr. Valliant was the founder of Fusion Pharmaceuticals, Inc., having held the title of Chief Executive Officer & Director from 2014 to 2024.
Dr. Valliant's current job is as a Professor at McMaster University, starting in 1999.
Dr. Valliant's education includes a doctorate from McMaster University.
Posizioni attive di John Valliant
| Società | Posizione | Inizio |
|---|---|---|
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Fondatore | 01/03/2008 |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1999 |
Precedenti posizioni note di John Valliant
| Società | Posizione | Fine |
|---|---|---|
| FUSN PHAR | Fondatore | 04/06/2024 |
Formazione di John Valliant
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fusion Pharmaceuticals, Inc.
Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
















